[A case of serous cystadenoma of the pancreas communicating with the pancreatic duct].

Department of Internal Medicine, Samsung medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, Korea.
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 12/2003; 42(5):440-3.
Source: PubMed

ABSTRACT Serous cystadenoma of the pancreas is a rare disease and is usually benign. Mucinous cystadenoma, another cystic neoplasm of the pancreas, has a malignant potential. Serous cystadenoma is usually composed of many small cysts lined by small, cuboidal or flattened cells containing abundant glycogen. With the finding of endoscopic retrograde pancreatography, a communication between the cyst and pancreatic duct is observed occasionally in the mucinous cystadenoma, but rarely in the case of serous cystadenoma of the pancreas. We experienced a case of serous cystadenoma of the pancreas that had a communication between a cyst and the pancreatic duct.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Pancreatic serous neoplasms are rare but account for the most common type of pancreatic cystic neoplasms. The vast majority of serous cystic tumours are benign (serous cystadenoma). A few cases of clinically more aggressive and metastatic serous tumours have been reported in the literature, and designated as malignant (serous cystadenocarcinoma). Due to the rarity of malignant pancreatic serous neoplasms, their true incidence is still unclear. Serous cystic neoplasms of the pancreas can be a diagnostic challenge, since they exhibit overlapping clinical, radiological and even histological features with other pancreatic cystic lesions, namely mucinous cystic tumours and pseudocysts. Complete surgical resection is curative.
    Current Diagnostic Pathology 04/2005; 11(2):102-109. DOI:10.1016/j.cdip.2004.11.003
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cross-sectional imaging is frequently used in the diagnosis of pancreatic cysts, but there can be overlap in radiographic appearance. We present a case of a patient with presumed intraductal papillary mucinous neoplasm (IPMN) who was ultimately found to have a serous cystadenoma in communication with the pancreatic duct. A literature search for serous cystadenoma communicating with the pancreatic duct was performed and the data was reviewed in the context of this case report. Three reports of patients with serous cystadenoma communicating with the pancreatic duct were identified. Review of current data revealed that endoscopic ultrasound (EUS) has an important role in distinguishing between pancreatic cystic lesions preoperatively. Distinguishing between serous and mucinous cystadenomas and IPMN is essential to guide appropriate management. Although communication with the pancreatic duct is usually pathognomonic of IPMN, rarely this may be a misdiagnosis of a serous cystadenoma and EUS may be necessary for further evaluation. If EUS cannot be performed, resection is favored to avoid undertreating a premalignant lesion.
    Journal of clinical gastroenterology 03/2010; 44(6):e133-5. DOI:10.1097/MCG.0b013e3181d3458d · 3.19 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: With more widespread use of imaging, cystic neoplasms of the pancreas are being diagnosed with increased frequency. Serous cystadenomas are the most common type of cystic neoplasm of the pancreas and have a natural history and malignant potential different than that of other cystic neoplasms. Although characteristic findings on imaging may be supportive, definitive diagnosis of these lesions often cannot be made by imaging alone. Endoscopic ultrasound with fine needle aspiration and cyst aspiration may facilitate the diagnosis, and after definitive diagnosis, patients with lesions that are small and asymptomatic may be followed with serial imaging. If definitive diagnosis cannot be made or if the patient is symptomatic, resection is warranted. In addition, large (> 4 cm) serous cystadenomas should be resected in appropriate surgical candidates given their propensity for growth and developing symptoms.
    Advances in Surgery 09/2009; 43:23-34. DOI:10.1016/j.yasu.2009.03.001